These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17323177)

  • 21. Comparative Effects of Ibandronate and Paclitaxel on Immunocompetent Bone Metastasis Model.
    Chung YS; Kang HC; Lee T
    Yonsei Med J; 2015 Nov; 56(6):1643-50. PubMed ID: 26446649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relations between radiograph texture analysis and microcomputed tomography in two rat models of bone metastases.
    Blouin S; Moreau MF; Baslé MF; Chappard D
    Cells Tissues Organs; 2006; 182(3-4):182-92. PubMed ID: 16914920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis.
    McClung MR; Wasnich RD; Recker R; Cauley JA; Chesnut CH; Ensrud KE; Burdeska A; Mills T;
    J Bone Miner Res; 2004 Jan; 19(1):11-8. PubMed ID: 14753731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
    Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
    Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bone quality].
    Ito M
    Nihon Rinsho; 2009 May; 67(5):921-5. PubMed ID: 19432110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New model for simulation of fracture repair in full-grown beagle dogs: model characterization and results from a long-term study with ibandronate.
    Bauss F; Schenk RK; Hört S; Müller-Beckmann B; Sponer G
    J Pharmacol Toxicol Methods; 2004; 50(1):25-34. PubMed ID: 15233964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of intermittent intravenous ibandronate injections on bone quality and micro-architecture in women with postmenopausal osteoporosis: the DIVA study.
    Recker RR; Ste-Marie LG; Langdahl B; Czerwinski E; Bonvoisin B; Masanauskaite D; Rowell L; Felsenberg D
    Bone; 2010 Mar; 46(3):660-5. PubMed ID: 19909829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Curcumin reduces trabecular and cortical bone in naive and lewis lung carcinoma-bearing mice.
    Yan L; Yee JA; Cao J
    Anticancer Res; 2013 Aug; 33(8):3153-61. PubMed ID: 23898073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positive alterations of viscoelastic and geometric properties in ovariectomized rat femurs with concurrent administration of ibandronate and PTH.
    Yang X; Muthukumaran P; DasDe S; Teoh SH; Choi H; Lim SK; Lee T
    Bone; 2013 Jan; 52(1):308-17. PubMed ID: 23069373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of combined humanPTH(1-34) and calcitonin treatment in ovariectomized rats.
    Washimi Y; Ito M; Morishima Y; Taguma K; Ojima Y; Uzawa T; Hori M
    Bone; 2007 Nov; 41(5):786-93. PubMed ID: 17707708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Once-monthly oral ibandronate provides significant improvement in bone mineral density in postmenopausal women treated with glucocorticoids for inflammatory rheumatic diseases: a 12-month, randomized, double-blind, placebo-controlled trial.
    Hakala M; Kröger H; Valleala H; Hienonen-Kempas T; Lehtonen-Veromaa M; Heikkinen J; Tuomiranta T; Hannonen P; Paimela L;
    Scand J Rheumatol; 2012 Aug; 41(4):260-6. PubMed ID: 22803768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lifelong administration of high doses of ibandronate increases bone mass and maintains bone quality of lumbar vertebrae in rats.
    Lalla S; Hothorn LA; Haag N; Bader R; Bauss F
    Osteoporos Int; 1998; 8(2):97-103. PubMed ID: 9666930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of novel bone-specific molecular targets of binge alcohol and ibandronate by transcriptome analysis.
    Himes R; Wezeman FH; Callaci JJ
    Alcohol Clin Exp Res; 2008 Jul; 32(7):1167-80. PubMed ID: 18537941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human parathyroid hormone 1-34 prevents bone loss in experimental biliary cirrhosis in rats.
    Dresner-Pollak R; Gabet Y; Steimatzky A; Hamdani G; Bab I; Ackerman Z; Weinreb M
    Gastroenterology; 2008 Jan; 134(1):259-67. PubMed ID: 18061175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feeding orange pulp improved bone quality in a rat model of male osteoporosis.
    Morrow R; Deyhim F; Patil BS; Stoecker BJ
    J Med Food; 2009 Apr; 12(2):298-303. PubMed ID: 19459729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of change patterns of microcomputed tomography 3-dimensional bone parameters as a high-throughput tool to evaluate antiosteoporotic effects of agents at an early stage of ovariectomy-induced osteoporosis in mice.
    Xiang A; Kanematsu M; Mitamura M; Kikkawa H; Asano S; Kinoshita M
    Invest Radiol; 2006 Sep; 41(9):704-12. PubMed ID: 16896306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lasofoxifene (CP-336,156) protects against the age-related changes in bone mass, bone strength, and total serum cholesterol in intact aged male rats.
    Ke HZ; Qi H; Chidsey-Frink KL; Crawford DT; Thompson DD
    J Bone Miner Res; 2001 Apr; 16(4):765-73. PubMed ID: 11316005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anabolic and antiresorptive drugs improve trabecular microarchitecture and reduce fracture risk following radiation therapy.
    Arrington SA; Fisher ER; Willick GE; Mann KA; Allen MJ
    Calcif Tissue Int; 2010 Sep; 87(3):263-72. PubMed ID: 20563797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ibandronate: pharmacology and preclinical studies.
    Russell RG
    Bone; 2006 Apr; 38(4 Suppl 1):S7-12. PubMed ID: 16531132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Once-monthly oral ibandronate improves biomechanical determinants of bone strength in women with postmenopausal osteoporosis.
    Lewiecki EM; Keaveny TM; Kopperdahl DL; Genant HK; Engelke K; Fuerst T; Kivitz A; Davies RY; Fitzpatrick LA
    J Clin Endocrinol Metab; 2009 Jan; 94(1):171-80. PubMed ID: 18840641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.